Evofem Biosciences (EVFM) Misses Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts EVFM Hot Sheet
Join SI Premium – FREE
Evofem Biosciences (OTC: EVFM) reported Q4 EPS of ($0.03). Revenue for the quarter came in at $7.1 million.
For earnings history and earnings-related data on Evofem Biosciences (EVFM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q1 EPS by 2c; Offers Guidance
- Deluxe Corp. (DLX) Tops Q3 EPS by 11c; offers guidance
- NACCO Industries (NC) Reports Q3 EPS of $1.44
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
